Type 1 diabetes advocacy through strategic investment

Leveraging the power of investment and corporate engagement to create a better world for individuals and families with Type 1 diabetes.

sketch
sketch
sketch
sketch
feature image
Strategic Investment

We invest in companies who have an impact on the diabetes community. We use those investments to engage leadership, vote on policies, and further the cause of those with Type 1 diabetes.

Corporate Engagement

We work to engage corporations and discuss ways to improve the lives and access for people living with diabetes that fit within their corporate strategy.

Community Connections

We connect organizations and the T1D community to ensure that every resource is available for individuals and families to manage this disease and live a full and healthy life.

About us

Giving a voice to
T1D families through

Strategic investments

Corporate engagement

Community Connections

Dr. Michael Gambrel
Dr. Michael Gambrel

Founder/CEO

Dr. Michael Gambrel
People Living with T1D <br>Around the World

8.4

Million

People Living with T1D
Around the World

Individuals Who Have Rationed Insulin Due to Cost in the U.S.

25

%

Individuals Who Have Rationed Insulin Due to Cost in the U.S.

Healthcare Expenditures and Lost Income due to T1D

16

Billion

Healthcare Expenditures and Lost Income due to T1D

Growth Rate of T1D<br> Diagnoses Annually

2.9

%

Growth Rate of T1D
Diagnoses Annually

Latest news & article directly from our blog

shape-1a
Give Without Spending a Penny!

Give Without Spending a Penny!

Sweet Share Inc. is excited to work with HundredX Causes to raise money without asking

Learn More
Sweet Share Achieves 501(c)(3) Nonprofit Status

Sweet Share Achieves 501(c)(3) Nonprofit Status

Press Release For Immediate Release Sweet Share Achieves 501(c)(3) Nonprofit Status June

Learn More
Introducing Sweet Share: Transforming the Future of Type

Introducing Sweet Share: Transforming the Future of Type

In a world where over 1.25 million Americans live with type 1 diabetes (T1D), the need

Learn More